1. Home
  2. DLB vs LNTH Comparison

DLB vs LNTH Comparison

Compare DLB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolby Laboratories

DLB

Dolby Laboratories

HOLD

Current Price

$58.03

Market Cap

5.9B

Sector

Miscellaneous

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$99.97

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLB
LNTH
Founded
1965
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.6B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
DLB
LNTH
Price
$58.03
$99.97
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$90.75
$87.00
AVG Volume (30 Days)
963.6K
922.1K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.28%
N/A
EPS Growth
N/A
N/A
EPS
1.84
2.91
Revenue
N/A
$343,374,000.00
Revenue This Year
$6.22
N/A
Revenue Next Year
$3.84
$14.19
P/E Ratio
$31.74
$34.36
Revenue Growth
N/A
3.62
52 Week Low
$48.26
$49.67
52 Week High
$73.01
$111.86

Technical Indicators

Market Signals
Indicator
DLB
LNTH
Relative Strength Index (RSI) N/A 40.87
Support Level N/A $99.92
Resistance Level N/A $101.43
Average True Range (ATR) 0.00 0.44
MACD 0.00 0.01
Stochastic Oscillator 0.00 0.93

Price Performance

Historical Comparison
DLB
LNTH

About DLB Dolby Laboratories

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: